Selected article for: "spike structural protein and structural protein"
Author: Julian Braun; Lucie Loyal; Marco Frentsch; Daniel Wendisch; Philipp Georg; Florian Kurth; Stefan Hippenstiel; Manuela Dingeldey; Beate Kruse; Florent Fauchere; Emre Baysal; Maike Mangold; Larissa Henze; Roland Lauster; Marcus Mall; Kirsten Beyer; Jobst Roehmel; Juergen Schmitz; Stefan Miltenyi; Marcel A Mueller; Martin Witzenrath; Norbert Suttorp; Florian Kern; Ulf Reimer; Holger Wenschuh; Christian Drosten; Victor M Corman; Claudia Giesecke-Thiel; Leif-Erik Sander; Andreas Thiel
Title: Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors
  • Document date: 2020_4_22
    • ID: 164yx77a_36
    Snippet: how SARS-CoV-2 specific humoral or cellular immunity mediates durable protection against 192 reinfection is unknown but will be one of the critically important fields of research in the 193 coming months. It has been demonstrated in mouse models that CD4 + as well as CD8 + T cell 194 responses directed against structural proteins such as spike or nucleocapsid protein of CoV critically contribute to viral clearance 17,36,37 . 196.....
    Document: how SARS-CoV-2 specific humoral or cellular immunity mediates durable protection against 192 reinfection is unknown but will be one of the critically important fields of research in the 193 coming months. It has been demonstrated in mouse models that CD4 + as well as CD8 + T cell 194 responses directed against structural proteins such as spike or nucleocapsid protein of CoV critically contribute to viral clearance 17,36,37 . 196

    Search related documents:
    Co phrase search for related documents
    • durable protection and nucleocapsid spike: 1, 2, 3
    • durable protection and structural protein: 1
    • durable protection and viral clearance: 1
    • mouse model and nucleocapsid spike: 1, 2, 3, 4, 5
    • mouse model and nucleocapsid spike protein: 1, 2, 3
    • mouse model and specific cellular humoral immunity: 1, 2
    • mouse model and structural protein: 1, 2, 3, 4, 5, 6, 7
    • mouse model and viral clearance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • nucleocapsid spike and SARS specific cellular humoral immunity: 1
    • nucleocapsid spike and specific cellular humoral immunity: 1, 2
    • nucleocapsid spike and structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67
    • nucleocapsid spike and viral clearance: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • nucleocapsid spike protein and structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
    • nucleocapsid spike protein and viral clearance: 1, 2, 3, 4
    • SARS specific cellular humoral immunity and specific cellular humoral immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • specific cellular humoral immunity and structural protein: 1
    • specific cellular humoral immunity and viral clearance: 1, 2, 3
    • structural protein and viral clearance: 1, 2
    • structural protein and viral clearance contribute: 1